This announcement informs that Shandong Xinhua Pharmaceutical Co., Ltd. has received the registration certificate for Carbonate Siviralam suspension. The product is classified as a pharmaceutical for oral use, with specifications of 0.8g and 2.4g. The registration is approved by the National Medical Products Administration, and the company aims to enhance its product portfolio.
Summary generated by AI · Always verify with source document
Drug Name: Carbonate Siviralam Suspension
Dosage Form: Oral Suspension
Specifications: 0.8g; 2.4g
Drug Category: Prescription Drug
Registration Category: Chemical Drug Class 3
Applicant: Shandong Xinhua Pharmaceutical Co., Ltd.
Application Matter: Drug Registration (Domestic Production)
Receiving Number: CYHS2401033, CYHS2401034
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.